Article in Biometrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Madeline R AbbottDepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, United States.ORCID 0000-0002-5344-3732
Walter H DempseyDepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, United States.
Inbal Nahum-ShaniInstitute for Social Research, University of Michigan, Ann Arbor, MI 48104, United States.
Lindsey N PotterDepartment of Population Health Sciences and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84108, United States.ORCID 0000-0001-6681-8145
David W WetterDepartment of Population Health Sciences and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84108, United States.
Cho Y LamDepartment of Population Health Sciences and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84108, United States.
Jeremy M G TaylorDepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, United States.
Funding
UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Pilot and Mentoring CoreP50DA054039 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LINDA M COLLINS, SUSAN A MURPHY · 2021 to 2026
$18.2M
Research and Methods CoreU54CA280812 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI JUSTIN D SMITH · 2023 to 2026
$9.3M
Novel Methods for Intensive Longitudinal Data in SMART Studies of Drug Abuse and HIVR01DA039901 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALMIRALL, DANIEL, NAHUM-SHANI, INBAL BILLIE · 2015 to 2024
$5.4M
Biostatistics Training Program in Cancer ResearchT32CA083654 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Veerabhadran Baladandayuthapani, Kelley McLain Kidwell · 2002 to 2026
$4.3M
Novel use of mHealth data to identify states of vulnerability and receptivity to JITAIs SupplementU01CA229437 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NAHUM-SHANI, INBAL BILLIE, WETTER, DAVID W · 2018 to 2022
$2.8M
Race/Ethnicity and the Process of Smoking CessationR01DA014818 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WETTER, DAVID W · 2001 to 2006
$2.0M
Leveraging ML algorithms and data integration techniques to improve efficiency of causal moderation analyses of micro-randomized trial dataR01GM152549 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Walter Dempsey · 2024 to 2026
$918k
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populationsR00CA252604 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI POTTER, LINDSEY · 2023 to 2025
$747k
Joint longitudinal and survival models for intensive longitudinal data from mobile health studies of smoking cessationF31DA057048 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ABBOTT, MADELINE · 2023 to 2024
The availability of mobile health (mHealth) technology has enabled increased collection of intensive longitudinal data (ILD). ILD have potential to capture rapid fluctuations in outcomes that may be associated with changes in the risk of an event. However, existing methods for jointly modeling longitudinal and event-time outcomes are not well-equipped to handle ILD due to the high computational cost. We propose a joint longitudinal and time-to-event model suitable for analyzing ILD. In this model, we summarize a multivariate longitudinal outcome as a smaller number of time-varying latent factors. These latent factors, which are modeled using an Ornstein-Uhlenbeck stochastic process, capture the risk of a time-to-event outcome in a parametric hazard model. We take a Bayesian approach to fit our joint model and conduct simulations to assess its performance. We use it to analyze data from an mHealth study of smoking cessation. We summarize the longitudinal self-reported intensity of 9 emotions as the psychological states of positive and negative affect. These time-varying latent states capture the risk of the first smoking lapse after attempted quit. Understanding factors associated with smoking lapse is of keen interest to smoking cessation researchers.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Bayesian joint longitudinal-survival model with a latent stochastic process for intensive longitudinal data. · full record | OpenQuestion